Determining the antiviral mechanism of MARCH2

Supawadee Umthong1,2, Uddhav Timilsina1, Mary D'Angelo1

  • 1Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States.

Insights

Human Membrane-associated RING-CH (MARCH) 2 protein restricts HIV-1 by preventing viral envelope glycoprotein incorporation. A specific amino acid and key domains in human MARCH2 are critical for this antiretroviral function.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Membrane-associated RING-CH (MARCH) 2 is an E3 ubiquitin ligase regulating cell surface proteins.
  • MARCH proteins, including MARCH1, 2, and 8, inhibit HIV-1 by blocking envelope glycoprotein incorporation into virions.
  • The precise mechanism of MARCH protein-mediated HIV-1 restriction requires further elucidation.

Approach:

  • Identified a specific amino acid in human MARCH2, absent in mouse MARCH2, essential for its antiretroviral activity.
  • Mapped the domains of human MARCH2 responsible for HIV-1 restriction and envelope glycoprotein binding.
  • Investigated the molecular interactions between human MARCH2 and HIV-1 envelope glycoproteins.

Key Points:

  • A single amino acid difference between human and mouse MARCH2 is critical for antiretroviral function.
  • Specific domains within human MARCH2 mediate both the restriction of HIV-1 and binding to its envelope glycoproteins.
  • This study provides a detailed mechanistic understanding of human MARCH2's antiviral action against HIV-1.

Conclusions:

  • Human MARCH2 possesses a specific amino acid crucial for its ability to restrict HIV-1.
  • The identified domains of human MARCH2 are key to its antiretroviral mechanism and interaction with viral components.
  • These findings advance our understanding of MARCH protein antiviral functions and have implications for broader MARCH protein research.

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
33
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
332
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
811
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K